Literature DB >> 27562585

Descriptive epidemiology of breast cancer in China: incidence, mortality, survival and prevalence.

Tong Li1, Claudia Mello-Thoms2, Patrick C Brennan2.   

Abstract

Breast cancer is the most common neoplasm diagnosed amongst women worldwide and is the leading cause of female cancer death. However, breast cancer in China is not comprehensively understood compared with Westernised countries, although the 5-year prevalence statistics indicate that approximately 11 % of worldwide breast cancer occurs in China and that the incidence has increased rapidly in recent decades. This paper reviews the descriptive epidemiology of Chinese breast cancer in terms of incidence, mortality, survival and prevalence, and explores relevant factors such as age of manifestation and geographic locations. The statistics are compared with data from the Westernised world with particular emphasis on the United States and Australia. Potential causal agents responsible for differences in breast cancer epidemiology between Chinese and other populations are also explored. The need to minimise variability and discrepancies in methods of data acquisition, analysis and presentation is highlighted.

Entities:  

Keywords:  Breast cancer; China; Incidence; Mortality; Prevalence; Survival

Mesh:

Year:  2016        PMID: 27562585     DOI: 10.1007/s10549-016-3947-0

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  95 in total

1.  MicroRNA-765 alleviates the malignant progression of breast cancer via interacting with EZH1.

Authors:  Zhen Zeng; Yichen Yang; Hengyu Wu
Journal:  Am J Transl Res       Date:  2019-07-15       Impact factor: 4.060

2.  [Targeted imaging ability of a biotinylated imaging probe Biotin-S-S-Rhodol for breast cancer cells in vitro].

Authors:  Bi-Juan Wu; Xing-Zi Zhou; Jing-Wen Sun; Cui-Wen Tan; Xin-Rong Wu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-01-20

3.  Latcripin-7A, derivative of Lentinula edodes C91-3, reduces migration and induces apoptosis, autophagy, and cell cycle arrest at G1 phase in breast cancer cells.

Authors:  Syed Riaz Ud Din; Mintao Zhong; Muhammad Azhar Nisar; Muhammad Zubair Saleem; Akbar Hussain; Kavish H Khinsar; Shahid Alam; Gohar Ayub; Sadia Kanwal; Xingyun Li; Wei Zhang; Xiaoli Wang; Anhong Ning; Jing Cao; Min Huang
Journal:  Appl Microbiol Biotechnol       Date:  2020-10-12       Impact factor: 4.813

4.  Identification of Important Modules and Biomarkers in Breast Cancer Based on WGCNA.

Authors:  Zelin Tian; Weixiang He; Jianing Tang; Xing Liao; Qian Yang; Yumin Wu; Gaosong Wu
Journal:  Onco Targets Ther       Date:  2020-07-12       Impact factor: 4.147

Review 5.  [Research progress of external volume expansion assisted autologous fat grafting for breast reconstruction].

Authors:  Xuan Ma; Facheng Li
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2022-03-15

6.  Performance evaluation of medical service for breast cancer patients based on diagnosis related groups.

Authors:  Xinkui Liu; Furong Liu; Lin Wang; MengFan Wu; LinPeng Yang; Le Wei
Journal:  BMC Health Serv Res       Date:  2021-05-24       Impact factor: 2.655

7.  The significance of dual-mode elastography in the diagnosis of breast lesions by physicians with different levels of experience.

Authors:  Sijing Huang; Xiuqin Ye; Keen Yang; Hongtian Tian; Zhimin Ding; Jing Chen; Jinfeng Xu; Fajin Dong
Journal:  Quant Imaging Med Surg       Date:  2022-02

8.  Knockdown of LINC00504 Inhibits the Proliferation and Invasion of Breast Cancer via the Downregulation of miR-140-5p.

Authors:  Tieying Hou; Long Ye; Shulin Wu
Journal:  Onco Targets Ther       Date:  2021-07-02       Impact factor: 4.147

9.  Effects of Tamoxifen vs. Toremifene on fatty liver development and lipid profiles in breast Cancer.

Authors:  Dandan Song; Yingying Hu; Biyu Diao; Rongrong Miao; Baodan Zhang; Yangjun Cai; Hanqian Zeng; Yuru Zhang; Xiaoqu Hu
Journal:  BMC Cancer       Date:  2021-07-10       Impact factor: 4.430

10.  Family interaction among young Chinese breast cancer survivors.

Authors:  Jiehui Xu; Xiyi Wang; Mengjie Chen; Yiwen Shi; Yun Hu
Journal:  BMC Fam Pract       Date:  2021-06-21       Impact factor: 2.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.